Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 16-Sep-24 5:30 PM View:  | Amylyx Pharmaceuticals, Inc. (AMLX) | 12-Sep-24 | Private Purchase | 40,000 | $2.53 | $101,368.00 | 18% 220.0K to 260.0K | |
| 18-Apr-24 8:23 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 16-Apr-24 | Grant | 91,180 | -- | -- | 57% 161.31K to 252.5K | |
| 07-Mar-24 4:05 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 05-Mar-24 | Market Sale | 1,792 | $18.73 | $33,560.40 | (1%) 163.11K to 161.31K | 11% |
| 28-Feb-24 6:44 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 26-Feb-24 | Grant | 40,000 | -- | -- | 32% 123.11K to 163.11K | |
| 11-Jan-24 5:11 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 09-Jan-24 | Market Sale | 2,716 | $16.33 | $44,347.10 | (2%) 125.82K to 123.11K | (2%) |
| 02-Nov-23 3:33 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 31-Oct-23 | Gift | 11,072 | -- | -- | 10% 114.75K to 125.82K | |
| 24-Aug-23 4:15 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 23-Aug-23 | Option Exercise | 18,165 | $6.88 | $124,975.00 | 17% 107.66K to 125.82K | |
| 18-May-23 8:54 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 16-May-23 | Option Exercise | 32,500 | $6.88 | $223,600.00 | 43% 75.16K to 107.66K | |
| 18-May-23 8:54 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 16-May-23 | Planned Option Sale | 32,500 | $26.94 | $875,451.00 | (30%) 107.66K to 75.16K | |
| 20-Mar-23 8:18 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 16-Mar-23 | Grant | 21,667 | -- | -- | 64% 34.01K to 55.68K | |
| 20-Mar-23 8:18 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 16-Mar-23 | Sale (Planned) | 32,500 | $31.89 | $1,036,460.00 | (58%) 55.68K to 23.18K | |
| 10-Jan-23 7:20 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 06-Jan-23 | Sale (Planned) | 2,658 | $36.30 | $96,481.20 | 8% 31.35K to 34.01K | |
| 04-Jan-23 9:33 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 30-Dec-22 | Option Exercise | 5,000 | $6.88 | $34,400.00 | 16% 31.67K to 36.67K | |
| 10-Jan-22 8:28 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 06-Jan-22 | Grant | 31,667 | -- | -- | 100% 0 to 31.67K | |
| 17-Jun-21 4:04 PM View: | Sage Therapeutics, Inc. (SAGE) | 16-Jun-21 | Market Purchase | 1,810 | $55.10 | $99,734.60 | 175% 1.03K to 2.85K | (< 1%) |
| 14-May-20 4:58 PM View: | Alkermes Plc. (ALKS) | 14-May-20 | Option Exercise | 21,983 | $11.74 | $258,080.00 | 10% 225.51K to 247.5K | |
| 03-Mar-20 4:27 PM View: | Alkermes Plc. (ALKS) | 01-Mar-20 | Payment of Exercise | 1,323 | $20.84 | $27,571.30 | (< 1%) 226.84K to 225.51K | (3%) |
| 03-Mar-20 4:27 PM View: | Alkermes Plc. (ALKS) | 01-Mar-20 | Option Exercise | 4,500 | -- | -- | 2% 222.34K to 226.84K | |
| 24-Feb-20 4:11 PM View: | Alkermes Plc. (ALKS) | 21-Feb-20 | Payment of Exercise | 1,712 | $20.24 | $34,650.90 | (< 1%) 224.05K to 222.34K | (6%) |
| 24-Feb-20 4:11 PM View: | Alkermes Plc. (ALKS) | 21-Feb-20 | Option Exercise | 5,825 | -- | -- | 3% 218.22K to 224.05K | |
| 18-Feb-20 4:07 PM View: | Alkermes Plc. (ALKS) | 17-Feb-20 | Payment of Exercise | 904 | $17.77 | $16,064.10 | (< 1%) 219.13K to 218.22K | (21%) |
| 18-Feb-20 4:07 PM View: | Alkermes Plc. (ALKS) | 17-Feb-20 | Option Exercise | 3,000 | -- | -- | 1% 216.13K to 219.13K | |
| 18-Feb-20 4:07 PM View: | Alkermes Plc. (ALKS) | 16-Feb-20 | Payment of Exercise | 1,172 | $17.77 | $20,826.40 | (< 1%) 217.3K to 216.13K | (21%) |
| 18-Feb-20 4:07 PM View: | Alkermes Plc. (ALKS) | 16-Feb-20 | Option Exercise | 3,375 | -- | -- | 2% 213.93K to 217.3K | |
| 17-Sep-19 7:06 PM View: | Alkermes Plc. (ALKS) | 13-Sep-19 | Option Exercise | 20,000 | $11.74 | $234,800.00 | 10% 193.93K to 213.93K | |
| 04-Feb-20 10:00 PM View: | Sage Therapeutics, Inc. (SAGE) | 29-Aug-19 | Gift | 1,500 | -- | -- | (59%) 2.54K to 1.03K | |
| 16-Aug-19 4:04 PM View: | Sage Therapeutics, Inc. (SAGE) | 15-Aug-19 | Option Exercise | 8,000 | $28.35 | $226,800.00 | 316% 2.54K to 10.54K | |
| 16-Aug-19 4:04 PM View: | Sage Therapeutics, Inc. (SAGE) | 15-Aug-19 | Market Option Sale (Planned) | 8,000 | $160.58 | $1,284,640.00 | (76%) 10.54K to 2.54K | |
| 16-Aug-19 4:04 PM View: | Sage Therapeutics, Inc. (SAGE) | 06-May-19 | Gift | 1,700 | -- | -- | (40%) 4.24K to 2.54K | |
| 06-May-19 6:21 PM View: | Sage Therapeutics, Inc. (SAGE) | 06-May-19 | Option Exercise | 8,000 | $8.92 | $71,360.00 | 189% 4.24K to 12.23K | |
| 06-May-19 6:21 PM View: | Sage Therapeutics, Inc. (SAGE) | 06-May-19 | Market Option Sale (Planned) | 8,000 | $162.22 | $1,297,760.00 | (65%) 12.23K to 4.24K | (7%) |
| 04-Mar-19 5:35 PM View: | Alkermes Plc. (ALKS) | 01-Mar-19 | Payment of Exercise | 1,323 | $34.44 | $45,564.10 | (< 1%) 197.25K to 195.93K | 38% |
| 04-Mar-19 5:35 PM View: | Alkermes Plc. (ALKS) | 01-Mar-19 | Option Exercise | 4,500 | -- | -- | 2% 192.75K to 197.25K | |
| 27-Feb-19 5:12 PM View: | Alkermes Plc. (ALKS) | 26-Feb-19 | Payment of Exercise | 772 | $33.92 | $26,186.20 | (< 1%) 193.52K to 192.75K | 37% |
| 27-Feb-19 5:12 PM View: | Alkermes Plc. (ALKS) | 26-Feb-19 | Option Exercise | 2,625 | -- | -- | 1% 190.9K to 193.52K | |
| 19-Feb-19 6:53 PM View: | Alkermes Plc. (ALKS) | 17-Feb-19 | Payment of Exercise | 875 | $32.54 | $28,472.50 | (< 1%) 191.77K to 190.9K | 34% |
| 19-Feb-19 6:53 PM View: | Alkermes Plc. (ALKS) | 17-Feb-19 | Option Exercise | 3,000 | -- | -- | 2% 188.77K to 191.77K | |
| 19-Feb-19 6:53 PM View: | Alkermes Plc. (ALKS) | 16-Feb-19 | Payment of Exercise | 1,098 | $32.54 | $35,728.90 | (< 1%) 189.87K to 188.77K | 34% |
| 19-Feb-19 6:53 PM View: | Alkermes Plc. (ALKS) | 16-Feb-19 | Option Exercise | 3,375 | -- | -- | 2% 186.49K to 189.87K | |
| 24-Jan-19 5:44 PM View: | Sage Therapeutics, Inc. (SAGE) | 23-Jan-19 | Option Exercise | 7,500 | $8.92 | $66,900.00 | 177% 4.24K to 11.73K | |
| 24-Jan-19 5:44 PM View: | Sage Therapeutics, Inc. (SAGE) | 23-Jan-19 | Market Option Sale (Planned) | 7,500 | $134.81 | $1,011,080.00 | (64%) 11.73K to 4.24K | (29%) |
| 11-Dec-18 7:36 PM View: | Alkermes Plc. (ALKS) | 07-Dec-18 | Grant | 5,500 | -- | -- | 3% 183.44K to 188.94K | |
| 11-Dec-18 7:36 PM View: | Alkermes Plc. (ALKS) | 07-Dec-18 | Payment of Exercise | 2,445 | $34.01 | $83,154.40 | (1%) 188.94K to 186.49K | 37% |
| 23-Aug-18 5:20 PM View: | Sage Therapeutics, Inc. (SAGE) | 22-Aug-18 | Gift | 765 | -- | -- | (15%) 5.0K to 4.24K | |
| 13-Jun-18 8:26 PM View: | Alkermes Plc. (ALKS) | 12-Jun-18 | Market Sale (Planned) | 16,842 | $50.00 | $842,179.00 | (8%) 200.28K to 183.44K | 57% |
| 08-May-18 4:51 PM View: | Sage Therapeutics, Inc. (SAGE) | 08-May-18 | Option Exercise | 7,000 | $8.92 | $62,440.00 | 140% 5.0K to 12.0K | |
| 08-May-18 4:51 PM View: | Sage Therapeutics, Inc. (SAGE) | 08-May-18 | Market Option Sale (Planned) | 7,000 | $154.00 | $1,078,000.00 | (58%) 12.0K to 5.0K | (13%) |
| 05-Mar-18 6:02 PM View: | Alkermes Plc. (ALKS) | 03-Mar-18 | Payment of Exercise | 1,029 | $60.05 | $61,791.40 | (< 1%) 201.31K to 200.28K | 64% |
| 05-Mar-18 6:02 PM View: | Alkermes Plc. (ALKS) | 03-Mar-18 | Option Exercise | 2,813 | -- | -- | 1% 198.5K to 201.31K | |
| 05-Mar-18 6:02 PM View: | Alkermes Plc. (ALKS) | 01-Mar-18 | Payment of Exercise | 1,326 | $57.41 | $76,125.70 | (< 1%) 199.82K to 198.5K | 63% |